Wegovy vs Compounded Semaglutide

Wegovy vs Compounded Semaglutide: the short answer

If cash price is the only factor, compounded semaglutide wins — but availability is now legally restricted and quality varies by pharmacy. Wegovy is the regulated, on-label option and now has lower self-pay pricing than it once did.

Both Wegovy and Compounded Semaglutide contain semaglutide, so the core medicine is the same. The practical differences come down to approved use, target dose, and price.

On cost alone, Wegovy tends to be the cheaper option — its lowest realistic monthly price starts around $0, versus about $149 for Compounded Semaglutide.

How each medication works

Wegovy is a GLP-1 receptor agonist taken as a once-weekly subcutaneous injection. It is FDA-approved for Chronic weight management and Cardiovascular risk reduction.

Compounded Semaglutide is a GLP-1 receptor agonist taken as a once-weekly subcutaneous injection. It is FDA-approved for no weight-loss indication, and is also used off-label for weight loss and weight management.

Because they share the same active ingredient, the main dosing difference is the target maintenance dose: 2.4 mg weekly for Wegovy versus Titrated per prescriber, often up to 2.4 mg weekly for Compounded Semaglutide.

Effectiveness: average weight loss

In clinical data, Wegovy was associated with roughly 15% average body-weight reduction over about 68 weeks (STEP 1 trial (semaglutide 2.4 mg)).

Compounded Semaglutide was associated with roughly 15% over about 68 weeks (Extrapolated from branded semaglutide trials; compounded formulations are not FDA-reviewed).

Head-to-head averages favor Wegovy, but individual results vary widely with dose, diet, activity, and how long you stay on treatment. These figures are trial averages, not guarantees.

Cost comparison

Wegovy: full cash price is around $1,349/mo. With a manufacturer savings program it can drop to about $499/mo, and telehealth routes run roughly $299–$599/mo.

Compounded Semaglutide: full cash price is around —. With savings it can drop to about —, and telehealth routes run roughly $149–$299/mo.

Use the cost calculator to plug in your insurance status and state — the cheapest route often depends on coverage far more than on which drug you pick.

Side effects and safety

The most common side effects overlap heavily: Wegovy lists nausea, diarrhea, vomiting, and constipation; Compounded Semaglutide lists nausea, diarrhea, vomiting, and constipation. Most are gastrointestinal and tend to ease as the dose is titrated up slowly.

Both carry serious warnings, including a boxed warning about the risk of thyroid C-cell tumors, and should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2. Only a licensed clinician can decide whether either is appropriate for you.

Insurance and how to get each

Wegovy: Covered by some commercial plans for obesity; Medicare added limited coverage tied to cardiovascular risk. Coverage varies widely by plan.

Compounded Semaglutide: Not covered by insurance. Paid out of pocket, usually through a telehealth membership.

If coverage is denied, most people compare a manufacturer savings program against a telehealth subscription or a compounded alternative where it is still legally available.

Which should you choose?

Since Wegovy and Compounded Semaglutide are the same molecule, the decision is usually about approval and access: pick the one your insurance is more likely to cover, or the one with the self-pay price that fits your budget.

Whichever you lean toward, run your specifics through the calculator and take our 60-second quiz to see which telehealth provider can actually get it to you for the least.